Modular CRISPR/Cas12a synergistic activation platform for detection and logic operations.

Area of Science:

• Molecular Biology
• Molecular Engineering
• Biotechnology

Background:

• CRISPR/Cas technology offers revolutionary capabilities in molecular biology and engineering.
• Emerging niche applications necessitate enhanced programmability and compatibility of CRISPR/Cas systems.
• Existing CRISPR/Cas tools face limitations in modular integration and fine-tuned activity control.

Purpose of the Study:

• To develop a novel, modular CRISPR/Cas12a synergistic activation platform (MCSAP) with enhanced programmability and compatibility.
• To demonstrate the ability to finely regulate Cas12a activity through adjustable DNA activator structures.
• To showcase MCSAP's versatility in performing diverse molecular tasks within integrated systems.

Main Methods:

• Designed a redundancy-based modular CRISPR/Cas12a synergistic activation platform (MCSAP).
• Investigated the impact of DNA activator redundancy (position, length, concentration) on Cas12a activity.
• Integrated MCSAP as a modular plug-in into upstream molecular networks for functional assays.

Main Results:

• Demonstrated precise regulation of Cas12a activity by tuning the characteristics of split DNA activators.
• Successfully implemented MCSAP for nucleic acid detection, enzyme detection, and logic operations.
• Validated MCSAP's compatibility and programmability as a modular effector in various molecular networks.

Conclusions:

• MCSAP provides a powerful, adaptable, and user-friendly platform for advanced molecular engineering.
• The modular design facilitates seamless integration of CRISPR/Cas12a into diverse molecular systems.
• This platform advances DNA nanotechnology, molecular engineering, and molecular biology applications.